Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORD36 (also known as snoRNA U36) is a non-coding RNA molecule located in the nucleolus of eukaryotic cells, where it functions in the biogenesis and modification of other small nuclear RNAs. It is a member of the box C/D snoRNA family, characterized by conserved C and D box sequence motifs, and functions primarily as a guide RNA directing site-specific 2'-O-methylation of ribosomal RNA (rRNA), specifically targeting 18S and 28S rRNA. SNORD36 is encoded within the intron of the ribosomal protein L7a gene. While canonical roles of C/D box snoRNAs include rRNA modification and ribosome biogenesis, SNORD36 has not currently been identified as a therapeutic target nor directly implicated in specific diseases or targeted by known drugs[2][1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORD36 (SNORD36).